Suche Medizinische Publikationen
Suche Abbildungen und Grafiken
Medizinprodukte - Labortechnik
Antidotarium (Stand 2012)
Phytokodex (Stand 2012)
Fachbücher
Patientenliteratur
Dia-Präsentation von Merck Gesellschaft mbH. Micardis(R) - Micardis Plus(R) - Klinische Wirksamkeit (39 Abbildungen) Übersicht
| ||||||||||||||||||
Abbildung 6: Morgendliche Blutdrucksenkung - Angiotensin-I-Rezeptorblocker Telmisartan has consistently shown superior reductions in blood pressure in the last 6 h of the dosing interval compared with other ARBs. This superiority is a consequence of telmisartan’s long duration of action. The evidence for this superiority is detailed in the following slides. |
Abbildung 6: Morgendliche Blutdrucksenkung - Angiotensin-I-Rezeptorblocker
Telmisartan has consistently shown superior reductions in blood pressure in the last 6 h of the dosing interval compared with other ARBs. This superiority is a consequence of telmisartan’s long duration of action. The evidence for this superiority is detailed in the following slides. |